JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 3,089 articles

Articles by James Calloway

Planet Fitness Shares Dive 31% on Slashed 2026 Guidance, Weak Membership Growth
Earnings

Planet Fitness Shares Dive 31% on Slashed 2026 Guidance, Weak Membership Growth

Planet Fitness shares tumbled 31% after the gym chain cut its 2026 outlook, citing weak first-quarter net member adds and lower same-club sales growth of about 1%.

PLNT
Himax Technologies Stock Jumps 30% on Q2 Guidance, Dividend, and AI Glasses Push
Earnings

Himax Technologies Stock Jumps 30% on Q2 Guidance, Dividend, and AI Glasses Push

Himax Technologies shares surged over 30% after the company forecast a Q2 rebound, declared a cash dividend, and highlighted its WiseEye AI for smart glasses and automotive chip wins.

StubHub Options Signal 13% Move Ahead of Q1 Earnings Release
Earnings

StubHub Options Signal 13% Move Ahead of Q1 Earnings Release

Options traders anticipate a 13% swing for StubHub (STUB) ahead of its May 13 earnings report. The company faces regulatory and competitive pressures.

STUB
Symbotic Stock Dips Despite Profit as $22.7B Backlog Faces Walmart Test
Earnings

Symbotic Stock Dips Despite Profit as $22.7B Backlog Faces Walmart Test

Symbotic shares slipped 2.3% despite posting a $9M profit and $676M revenue, as the $22.7B backlog faces heavy reliance on a single customer.

SYM WMT
Howmet Aerospace Surges on Strong Q1 Results, Lifts 2026 Outlook
Earnings

Howmet Aerospace Surges on Strong Q1 Results, Lifts 2026 Outlook

Howmet Aerospace reported strong Q1 results, beating estimates and raising its 2026 outlook amid robust demand from commercial aerospace and defense.

HWM BA RTX GE
Novavax Surges on Pfizer Deal, Q1 Revenue Beat Despite Weak Vaccine Sales
Earnings

Novavax Surges on Pfizer Deal, Q1 Revenue Beat Despite Weak Vaccine Sales

Novavax reported Q1 revenue of $139.5M, beating estimates, driven by $30M from Pfizer's Matrix-M license. Shares rose further as licensing income offset weak COVID vaccine sales.

NVAX PFE SNY MRNA
Live Nation's Ticketmaster Axes 350 Jobs Amid Antitrust Overhaul
Regulation

Live Nation's Ticketmaster Axes 350 Jobs Amid Antitrust Overhaul

Ticketmaster has laid off 350 employees, or 8% of its global workforce, as parent Live Nation restructures amid a pending antitrust ruling and a $371 million operating loss.

LYV
Shake Shack Stock Tumbles 28% on Q1 Loss, Rising Beef Costs, and CFO Change
Earnings

Shake Shack Stock Tumbles 28% on Q1 Loss, Rising Beef Costs, and CFO Change

Shake Shack shares plunged 28% on Thursday after the burger chain reported a quarterly loss and missed revenue estimates. Rising beef costs and a CFO transition added to investor concerns.

SHAK
IREN Stock Rises Ahead of Q3 Earnings; Mirantis Deal and AI Pivot Under Scrutiny
Earnings

IREN Stock Rises Ahead of Q3 Earnings; Mirantis Deal and AI Pivot Under Scrutiny

IREN Ltd. shares rose 1.6% to $61.94 ahead of fiscal Q3 earnings, with focus on AI cloud revenue from its $625M Mirantis deal and the new Sweetwater 1 data center.

IREN MSFT DELL
SoundHound AI Earnings Preview: Options Signal 16% Swing as OASYS Launch and LivePerson Deal Loom
Earnings

SoundHound AI Earnings Preview: Options Signal 16% Swing as OASYS Launch and LivePerson Deal Loom

SoundHound AI shares rose 2.3% to $9.59 ahead of Q1 earnings. Options pricing implies a nearly 16% swing. Wall Street expects $42.56M in revenue and a 5-cent loss per share.

SOUN
Beyond Meat Plunges 14% on Weak Q2 Forecast Amid Plant-Protein Rebrand
Earnings

Beyond Meat Plunges 14% on Weak Q2 Forecast Amid Plant-Protein Rebrand

Beyond Meat shares tumbled 14% after the company projected Q2 revenue of $60-$65 million, below analyst expectations, as Q1 sales continued to decline.

BYND
Oklo Gains NRC Approval for Aurora Design, but Commercial Hurdles Remain
Regulation

Oklo Gains NRC Approval for Aurora Design, but Commercial Hurdles Remain

Oklo Inc. received NRC approval for its Aurora powerhouse design, halving the review time. Yet, the company has no built plants or binding power deals, and faces significant hurdles.

OKLO